Clinical Trial

Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project

Recruiting
View on ClinicalTrials.gov →
Summary
To collect data and samples from participants with cancer who also have invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-10; most recent amendment 2026-07-13.
Status change: Not Yet Recruiting → Recruiting 2026-07-13
Trial Details
NCT Number NCT06878144
Lead Sponsor M.D. Anderson Cancer Center
Conditions Mucormycosis
Enrollment 300 participants
Start Date 2025-10-20
Primary Completion 2030-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-14